[1] Guo X, Ma WJ, Zhang F, et al. Recent advances in the research of an endemic osteochondropathy in China: Kashin-Beck disease. Osteoarthritis Cartilage, 2014; 22, 1774−83. doi:  10.1016/j.joca.2014.07.023
[2] Wei S, Wei YY, Gong YQ, et al. Metabolomics as a valid analytical technique in environmental exposure research: application and progress. Metabolomics, 2022; 18, 35. doi:  10.1007/s11306-022-01895-7
[3] Guo Xiong. Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi province, PR China. Int Orthop, 2001; 25, 147−50. doi:  10.1007/s002640100248
[4] Zhao ZJ, Li Q, Yang PZ, et al. Selenium: a protective factor for Kaschin–Beck disease in Qing-Tibet Plateau. Biol Trace Elem Res, 2013; 153, 1−4. doi:  10.1007/s12011-013-9686-8
[5] Jiang M, Chen TL, Feng H, et al. Serum metabolic signatures of four types of human arthritis. J Proteome Res, 2013; 12, 3769−79. doi:  10.1021/pr400415a
[6] Loeser RF, Pathmasiri W, Sumner SJ, et al. Association of urinary metabolites with radiographic progression of knee osteoarthritis in overweight and obese adults: an exploratory study. Osteoarthritis Cartilage, 2016; 24, 1479−86. doi:  10.1016/j.joca.2016.03.011
[7] Zhu L, Zhao ZJ, Ren XB, et al. Serum metabonomics of articular cartilage destruction induced by T-2 toxin in Wistar Rats. Biomed Environ Sci, 2018; 31, 76−80.
[8] Liu JT, Guo X, Ma WJ, et al. Mitochondrial function is altered in articular chondrocytes of an endemic osteoarthritis, Kashin-Beck disease. Osteoarthritis Cartilage, 2010; 18, 1218−26. doi:  10.1016/j.joca.2010.07.003
[9] Jiang H, Liu J, Qin XJ, et al. Gas chromatography-time of flight/mass spectrometry-based metabonomics of changes in the urinary metabolic profile in osteoarthritic rats. Exp Ther Med, 2018; 15, 2777−85.
[10] Li SY, Cao JL, Caterson B, et al. Proteoglycan metabolism, cell death and Kashin-Beck disease. Glycoconj J, 2012; 29, 241−8. doi:  10.1007/s10719-012-9421-2